NutriBand (NTRB) Cash & Current Investments (2016 - 2026)
NutriBand's (NTRB) quarterly Cash & Current Investments came in at $4.6 million in Q1 2026, up 6.1% year-on-year from $4.3 million in Q1 2025, and down 13.88% quarter-over-quarter from $5.3 million in Q4 2025.
NutriBand (NTRB) Cash & Current Investments (2016 - 2026) Analysis & Trends
NutriBand has disclosed Cash & Current Investments across 11 years of filings, most recently posting $4.6 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $4.6 million, up 6.1% year-over-year; the trailing twelve-month figure through Jan 2026 was $4.6 million (up 6.1% YoY), and the FY2026 annual result was $4.6 million, up 6.1% from the prior year.
- Cash & Current Investments came in at $4.6 million for Q1 2026 at NutriBand, down from $5.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $8.3 million in Q2 2024 to a low of $492942.0 in Q1 2024.
- The 5-year median for Cash & Current Investments is $4.0 million (2022), against an average of $4.0 million.
- Across the five-year window, Cash & Current Investments soared 3118.48% in 2022 and plunged 75.17% in 2024, its largest moves.
- NutriBand's Cash & Current Investments stood at $2.8 million in 2022, then tumbled by 55.07% to $1.3 million in 2023, then jumped by 350.33% to $5.7 million in 2024, then fell by 6.77% to $5.3 million in 2025, then fell by 13.88% to $4.6 million in 2026.
- The last three Cash & Current Investments figures came in at $4.6 million (Q1 2026), $5.3 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | NutriBand | 41.21 Mn | 36.63 Mn | 88,941.00 | 4.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 4.57 Mn |
| Oct 31, 2025 | 5.31 Mn |
| Jul 31, 2025 | 7.00 Mn |
| Apr 30, 2025 | 2.96 Mn |
| Jan 31, 2025 | 4.31 Mn |
| Oct 31, 2024 | 5.70 Mn |
| Jul 31, 2024 | 6.76 Mn |
| Apr 30, 2024 | 8.35 Mn |
| Jan 31, 2024 | 492,942.00 |
| Oct 31, 2023 | 1.27 Mn |
| Jul 31, 2023 | 2.33 Mn |
| Apr 30, 2023 | 1.28 Mn |
| Jan 31, 2023 | 1.99 Mn |
| Oct 31, 2022 | 2.82 Mn |
| Jul 31, 2022 | 3.34 Mn |
| Apr 30, 2022 | 4.01 Mn |
| Jan 31, 2022 | 4.89 Mn |
| Oct 31, 2021 | 5.49 Mn |
| Jul 31, 2021 | 304,258.00 |
| Apr 30, 2021 | 410,754.00 |